Patent holdings for IPC class A61K 31/4748

Total number of patents in this class: 405

10-year publication summary

39
32
32
38
43
24
20
34
21
16
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Antecip Bioventures II LLC
378
24
Alkermes Pharma Ireland Limited
255
12
Purdue Pharma L.P.
433
12
Novartis AG
10175
11
Camurus AB
145
8
Indivior UK Limited
191
8
Edenbridge Pharmaceuticals, LLC
28
8
Genetic Disease Investigators, LLC
11
7
Wyeth LLC
600
6
Concert Pharmaceuticals, Inc.
242
6
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
876
6
Centre National de La Recherche Scientifique
11077
5
Duke University
3186
5
Hangzhou Bensheng Pharmaceutical Co., Ltd.
16
5
Keyview Labs, Inc.
16
5
Kura Oncology, Inc.
134
5
Macau University of Science and Technology
95
5
Ortho-nutra, LLC
15
5
Axsome Therapeutics, Inc.
425
4
LTS Lohmann Therapie-Systeme AG
678
4
Other owners 254